Cibus 

$1.3600
51
+$0.07+5.43% Thursday 20:00

Statistics

Day High
1.41
Day Low
1.28
52W High
4.19
52W Low
1.09
Volume
808,200
Avg. Volume
-
Mkt Cap
74.07M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-7.63
-5.18
-2.72
-0.27
Expected EPS
-0.27
Actual EPS
N/A

Financials

-5,898.36%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
8.52MRevenue
-502.78MNet Income

Analyst Ratings

3.00Average Price Target
The highest estimate is 3.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CBUS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap4.9B
CRISPR Therapeutics is involved in gene editing, a technology that can be applied in agriculture to develop crops with desirable traits, similar to Cibus's gene editing platform for crop improvement.
Editas Medicine
EDIT
Mkt Cap383.65M
Editas Medicine operates in the gene editing space using CRISPR technology, which can be applied to agriculture, making it a competitor in the development of genetically modified crops.
Intellia Therapeutics
NTLA
Mkt Cap1.69B
Intellia Therapeutics is another company working with CRISPR technology for gene editing, which has applications in agriculture for crop improvement, competing with Cibus's offerings.
Evogene
EVGN
Mkt Cap6.92M
Evogene is a biotechnology company that uses computational biology to improve crop productivity and biofuel production, directly competing with Cibus in the agricultural biotech sector.
Corteva
CTVA
Mkt Cap50.92B
Corteva Agriscience is focused on providing agricultural products including seeds and crop protection, directly competing with Cibus in the aim to improve crop yields and resilience.
SYLA Technologies. American Depositary Shares
SYT
Mkt Cap60.16M
Syngenta is a major player in the agribusiness, focusing on agrochemicals and seeds, competing with Cibus in the development of improved crops through biotechnology.
Dow
DOW
Mkt Cap24.4B
DowDuPont, now split into DuPont and Dow, was involved in agricultural sciences and biotechnology, competing with Cibus in the development of advanced agricultural products.

About

Cibus, Inc. is an agricultural technology company dedicated to innovating and commercializing advanced plant characteristics. The firm's business model involves creating these beneficial traits and then licensing them to seed producers, generating revenue through royalty payments. Cibus primarily concentrates its efforts on two key areas: 1. Boosting Farm Productivity: This involves developing traits that enable farmers to achieve greater crop yields while simultaneously minimizing their need for synthetic crop protection agents and fertilizers. 2. Pioneering Sustainable Components: The company also engineers environmentally responsible ingredient alternatives, offering corporations solutions to replace materials derived from fossil fuels or those whose manufacturing processes significantly contribute to greenhouse gas emissions. The company's headquarters are located in San Diego, California.
Show more...
CEO
Dr. Peter R. Beetham B.Sc., Ph.D.
Employees
157
Country
United States
ISIN
US17166A1016

Listings

0 Comments

Share your thoughts

FAQ

What is Cibus stock price today?
The current price of CBUS is $1.36 USD — it has increased by +5.43% in the past 24 hours. Watch Cibus stock price performance more closely on the chart.
What is Cibus stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cibus stocks are traded under the ticker CBUS.
Is Cibus stock price growing?
CBUS stock has risen by +10.57% compared to the previous week, the month change is a -1.45% fall, over the last year Cibus has showed a -9.33% decrease.
What is Cibus market cap?
Today Cibus has the market capitalization of 74.07M
When is the next Cibus earnings date?
Cibus is going to release the next earnings report on August 06, 2026.
What were Cibus earnings last quarter?
CBUS earnings for the last quarter are -0.33 USD per share, whereas the estimation was -0.27 USD resulting in a -22.22% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cibus revenue for the last year?
Cibus revenue for the last year amounts to 8.52M USD.
What is Cibus net income for the last year?
CBUS net income for the last year is -502.78M USD.
How many employees does Cibus have?
As of June 21, 2026, the company has 157 employees.
In which sector is Cibus located?
Cibus operates in the Health & Wellness sector.
When did Cibus complete a stock split?
The last stock split for Cibus was on April 25, 2023 with a ratio of 1:10.
Where is Cibus headquartered?
Cibus is headquartered in San Diego, United States.